Abstract Soluble epoxide hydrolase (sEH) converts epoxyeicosatrienoic acids that are endothelium-derived hyperpolarizing factors into less active dihydroxyeicosatrienoic acids. Previously, we reported a decrease in adenosine A 1 receptor (A 1 AR) protein levels in sEH knockout (sEH -/-) and an increase in sEH and A 1 AR protein levels in A 2A AR -/-mice. Additionally, K ATP channels are involved in adenosine receptor (AR)-dependent vascular relaxation. Thus, we hypothesize that a potential relationship may exist among sEH over-expression, A 1 AR upregulation, inactivation of K ATP channels, and increased in vascular tone. We performed DMT myograph muscle tension measurements and western blot analysis in isolated mouse mesenteric arteries (MAs) from wild-type (WT) and endothelial over-expression of sEH (Tie2-sEH Tr) mice. Our data revealed that NECA (a nonselective adenosine receptors agonist)-induced relaxation was significantly reduced in Tie2-sEH Tr mice, and CCPA (A 1 AR agonist)-induced contraction was increased in Tie2-sEH Tr mice. A 1 AR-dependent contraction in Tie2-sEH Tr mice was significantly attenuated by pharmacological inhibition of CYP4A (HET0016, 10 lM), PKCa (GO6976, 1 lM), and ERK1/2 (PD58059, 1 lM). Our western blot analysis revealed significantly higher basal protein expression of CYP4A, A 1 AR, and reduced p-ERK in MAs of Tie2-sEH Tr mice. Notably, pinacidil (K ATP channel opener)-induced relaxation was also significantly reduced in MAs of Tie2-sEH Tr mice. Furthermore, K ATP channeldependent relaxation in MAs was enhanced by inhibition of PKCa and ERK1/2 in WT but not Tie2-sEH Tr mice. In conclusion, our data suggest that over-expression of sEH enhances A 1 AR-dependent contraction and reduces K ATP channel-dependent relaxation in MAs. These results suggest a possible interaction between sEH, A 1 AR, and K ATP channels in regulating vascular tone.
Introduction
Soluble epoxide hydrolase (sEH) is an enzyme found in the cytosol and peroxisomes of variety of tissues that regulate the conversion of epoxyeicosatrienoic acids (EETs) to their corresponding less active diols, dihydroxyeicosatrienoic acids [1] [2] [3] . EETs are produced by the metabolism of arachidonic acid (substrate) through CYP-epoxygenases, which are known to play an important role in protection against ischemic injury, and act as vasodilators in arteries from the brain, intestines, skeletal muscle, heart, and aorta [4] [5] [6] [7] [8] [9] [10] . In arteries, sEH is highly expressed in endothelial cells and present lesser in smooth muscle cells [7, 11, 12] . Genetic deletion and inhibition of sEH protected against myocardial ischemia-reperfusion injury, improved vascular function, and decreased blood pressure in various disease models [13] [14] [15] [16] . Endothelial over-expression of sEH impaired vasodilation response in the mouse cerebral artery & Mohammed A. Nayeem mnayeem@hsc.wvu.edu [17] ; however, the effect of sEH over-expression in mesenteric arteries has not been investigated yet. Adenosine regulates vascular function by acting on four different adenosine receptors (ARs). Stimulation of A 1 AR or A 3 AR results in vascular contraction, while stimulation of A 2A AR or A 2B AR produces vascular relaxation [18] . We previously reported enhanced adenosine receptors (AR)-dependent vascular relaxation in the aorta of sEH knockout ( -/-) mice [19] . This increase in relaxation was attributed to enhanced A 2A AR and decreased A 1 AR protein expression [19] . In A 2A AR -/-mouse aorta, we found higher expression of A 1 AR [20] and sEH [21] . Moreover, in mouse aorta of A 2A AR -/-, sEH inhibition significantly reduced A 1 AR-induced vascular contraction [21] . These findings strongly indicate a relationship between sEH and ARs, especially A 1 AR, which plays an important role in the regulation of vascular tone.
A 1 AR-mediated vascular contraction occurs through the activation of protein kinase C-a (PKCa) leading to p42/p44 MAPK (ERK1/2) phosphorylation in coronary artery smooth muscle cells [22, 23] . We reported that A 1 AR activation resulted in contraction via cytochrome P450 epoxygenase type 4A (CYP4A), PKCa, and ERK1/2 in mouse aorta [24, 25] . Moreover, in A 2A AR -/-mouse aorta, contraction occurred through CYP4A and ERK1/2 via upregulation of A 1 AR and PKCa [20] . We recently showed, in mouse mesenteric arteries (MAs), that, after acute angiotensin II stimulation, A 1 AR-dependent vascular contraction involved CYP4A and ERK1/2 [26] . Thus, it is likely that sEH modulates A 1 AR-dependent vascular contraction, which involves CYP4A, PKCa, and ERK1/2.
ATP-sensitive potassium (K ATP ) channels regulate the membrane potential of smooth muscle, thereby playing a major role in vascular function [27] . K ATP channel phosphorylation by PKC negatively regulates channel function, affecting contractility in arteries [28, 29] . Interestingly, A 1 AR-dependent aortic contraction was dependent upon the activation of PKCa [20, 24, 25] . In A 2A AR -/-mouse aorta, higher A 1 AR expression [20] and reduced K ATP channel-dependent vascular relaxation were observed [29] . In mouse MAs, K ATP channels were involved in A 2B ARdependent vascular relaxation [26] . Notably, in wild-type (WT) mice, sEH inhibition resulted in enhanced A 2A ARdependent aortic relaxation [21] . Thus, sEH may regulate K ATP channel-dependent vascular relaxation, which involves A 1 AR, CYP4A, ERK1/2, and PKCa.
In the present study, we investigated the role of sEH in the regulation of MA vascular tone. In mouse MAs, vascular contraction is A 1 AR-dependent, while A 2B AR is responsible for relaxation [26, 30] . Interestingly, A 2A AR has no functional role [26, 30] , while A 2B AR-dependent vascular relaxation involves K ATP channels [26] . Similar to findings from A 2A R -/-mouse aorta [20] , MAs from A 2B AR -/-mice showed higher A 1 AR expression [30] . Thus, we hypothesized that over-expression of sEH in Tie2-sEH Tr mice enhances A 1 AR-dependent vascular contraction and reduce K ATP channel-dependent vascular relaxation in MAs. We found reduced K ATP channel-dependent relaxation, and enhanced A 1 AR-dependent contraction involving CYP4A, PKCa, and ERK1/2.
Materials and methods

Animals
Tie2-sEH Tr mice were developed by Schlaeger and coworkers [31] . Human sEH cDNA (NM001979) was amplified with primers (Fwd:5 0 -TAAGCTTGGCTGCAG ACCCGCCGCCATGACG-3 0 , Rev:5 0 TAGCGGCCGCTC TACATCTTTGAGACCACC-3 0 ) and subcloned downstream of the murine Tie2 promoter and upstream of the Tie2 full enhancer sequences [31] . Tie2-sEH Tr mice were provided by Dr. Darryl Zeldin from the National Institute of Environmental Health Sciences/National Institutes of Health (NIH) and were on a pure C57BL/6 genetic background. Immunohistochemistry analysis of Tie2sEH Tr mouse brains for human sEH revealed higher expression of sEH in vascular endothelium of blood vessels [17] . All animal care and experimentation protocols were approved and carried out in accordance with the West Virginia University Institutional Animal Care and Use Committee and were in accordance with the principles and guidelines of the NIH's Guide for the Care and Use of Laboratory Animals. Both male and female mice (14-18 weaks old) in equal ratio were used for isolation of MAs in our study.
Materials
50-(N-ethylcarboxamido) adenosine (NECA), 2-chloro-N cyclopentyladenosine (CCPA), phenylephrine (PE), acetyl choline (ACh), PD98059, and all other chemicals were purchased from Sigma-Aldrich. HET0016 and GO6976 were purchased from Sigma-Aldrich and Cayman chemicals, respectively. Antibodies CYP4A sc-271983, p-ERK sc-7383, ERK1 sc-93, sEH sc-166961, and actin sc-47778 were purchased from Santa Cruz Biotechnology, Santa Cruz, CA. PKCa was purchased from BD Transduction Labs, San Diego, CA. A 1 AR antibody was purchased from Sigma-Aldrich.
Muscle tension measurement
A DMT (Danish Myo Technology A/S, Aarhus, Denmark) myograph system was used to perform muscle tension measurements as described previously [26] . After anesthetizing the mice with pentobarbital sodium (100 mg/kg, intraperitoneally), the mouse mesentery with intestines was carefully excised and placed in cold oxygenated and (5 % CO 2 in diameter) were isolated and mounted on the DMT myograph with continuous oxygenation at 37°C. A preload of 300 mg was given to the MAs and equilibrated for 90 min. The viability of the arteries and the presence of endothelium were tested using KCl (50 mM) and ACh (1 lM), respectively. Concentration response curves were obtained in MAs precontracted with PE (1 lM). The muscle tension generated in each concentration response curve was plotted and normalized to the corresponding % contraction to the basal tension obtained using PE (1 lM).
Intact endothelium was present in all of our muscle tension measurement experiments.
Pharmacological inhibitors were used to study the role of CYP4A (HET0016 10 lM) and ERK1/2 (PD98059 1 lM) [26] . The role of PKCa was studied using GO6976 (1 lM) [25] . MAs were preincubated with or without these inhibitors (10 min), and concentration responses curves to NECA, CCPA, and pinacidil were obtained.
Western blotting
Western blot analysis was performed as described previously [26] . MAs isolated from WT and Tie2-sEH Tr mice were homogenized with 125 lL of RIPA lysis and extraction buffer mixed with 1 mM of Na3VO4, 1 mg/mL of leupeptin and 1 mM NaF, vortexed, and centrifuged for 10 min at 10,000 rpm at 4°C. Protein was estimated by Lowry's method using Bio-Rad Laboratories protein assay concentrate. Samples (2-5 lg of total protein) were loaded into slab gels (10 % acrylamide; 1.5 mm thick), separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis, and transferred to nitrocellulose membranes (Hybond-ECL). Membranes were blocked with 5 % nonfat dry milk for 45 min and incubated overnight with primary antibodies. BSA (5 %) was used to block the membrane when evaluating p-ERK expression. All antibody dilutions were 1:1000. All membranes were developed using enhanced chemiluminescence (Amersham BioSciences) and X-ray film. Densitometry analysis was performed using Multi Guage V3.0 software. The data obtained were normalized to actin and presented as the normalized ratio (% change) of target protein to WT protein expression.
Statistical analysis
All data are presented as mean ± standard error. Data in concentration response curves (CRC) were analyzed between groups at the same concentrations. Comparisons between two groups were made using Student's t test. ANOVA, followed by Tukey's test, was used to compare significance between three or more groups. Two-way ANOVA was used to compare the statistical relationship between concentration response curves. Values at p \ 0.05 were considered statistically significant. In all data, ''n'' represents the number of animals used to perform experiments.
Results
Enhanced vascular contraction was present in MAs from Tie2-sEH Tr mice MAs isolated from WT and Tie2-sEH Tr mice were used to study vascular tone regulation by sEH. Higher sEH protein expression was noted in MAs from Tie2-sEH Tr mice (Fig. 1a) . Muscle tension measurement studies showed significantly higher contraction to KCl (0.322 ± 0.015 vs. 0.274 ± 0.014 g, p \ 0.05, data not shown) and PE (0.343 ± 0.024 vs. 0.265 ± 0.019 g, Fig. 1b) in MAs from Tie2-sEH Tr mice compared to WT mice, respectively. Notably, acetylcholine-induced relaxation was comparable between MAs from WT and Tie2-sEH Tr mice (Fig. 1c) , suggesting that the endothelial function was intact in our in vitro studies. Thus, over-expression of endothelial sEH altered the contractile responses in MAs.
Enhanced A 1 AR-dependent vascular contraction in MAs isolated from Tie2-sEH Tr mice
There is strong evidence suggesting that sEH modulates A 1 AR-dependent signaling mechanisms, thereby regulating vascular tone; thus, we investigated alterations in AR-dependent signaling mechanisms in Tie2-sEH Tr mice. Muscle tension studies revealed that a non-selective adenosine agonist (NECA)-induced vascular relaxation was significantly inhibited in Tie2-sEH Tr mice compared to WT mice (Fig. 2a, b) . The muscle tensions generated in response to NECA (5 nM, 50 nM and 0.5 lM) in WT were (in %) -22.81 ± 5.614, -21.70 ± 4.290, and -62.58 ± 6.130, respectively (Fig. 2c) . In Tie2-sEH Tr mice, muscle tensions were -8.213 ± 5.413 (p = 0.724), -7.443 ± 5.049 (p \ 0.05), and -52.41 ± 5.970 (ns), respectively (Fig. 2c) .
The selective A 1 AR agonist CCPA was used to create concentration response curves in MAs. Data showed enhanced CCPA-induced contraction in MAs from Tie2-sEH Tr mice (Fig. 3a) . In addition, enhanced contraction to CCPA was significantly reduced after pre-treatment of MAs with pharmacological inhibitors, namely HET0016 (CYP4A), 10 lM; PD58059 (ERK1/2), 1 lM; and GO6976 (PKCa), 1 lM (Fig. 3b) for 10 min. This suggests that sEH enhanced A 1 AR-dependent vascular contraction, which are dependent on CYP4A, ERK1/2, and PKCa in MAs.
Increased levels of A 1 AR, CYP4A, and reduced p-ERK, but not PKCa, were present in MAs from Tie2-sEH Tr mice
To determine the molecular players involved in altered A 1 AR-dependent vascular responses in Tie2-sEH Tr mice, protein expression of A 1 AR, CYP4A, p-ERK, and PKCa was measured by western blot. Our data revealed significant upregulation of A 1 AR and CYP4A in MAs from Tie2-sEH Tr mice (Fig. 4a, b) . Furthermore, significantly reduced levels of basal p-ERK (Fig. 5a, b) with relatively higher levels ERK1/2 (Fig. 5c , p = 0.0537) were present in MAs from Tie2-sEH Tr mice. Notably, PKCa expression was similar between WT and Tie2-sEH Tr mice (Fig. 5d, e) . Thus, indicating the involvement of A 1 AR, CYP4A and basal p-ERK/t-ERK ratio in altered responses in Tie2-sEH Tr mice.
K ATP channel-dependent vascular relaxation was reduced in MAs from Tie2-sEH Tr mice Pinacidil (a K ATP channel opener)-induced concentration response curves were performed to investigate the involvement of sEH in K ATP channel-dependent vascular relaxation. Pinacidil-induced relaxation was significantly reduced in MAs from Tie2-sEH Tr mice compared to WT (Fig. 6a-c) . The muscle tensions generated in response to pinacidil (10 nM, 100 nM, and 1 lM) in WT were (in %) -18.40 ± 4.184, -27.21 ± 3.455, and -75.82 ± 3.992 mg, respectively. In Tie2-sEH Tr mice, the muscle tensions were -5.151 ± 4.575, -10.90 ± 5.005, and -61.54 ± 4.696 mg, respectively. Mechanisms regulating K ATP channel-dependent vascular relaxation were further investigated by pre-incubating MAs with various pharmacological inhibitors for 10 min. In WT mice but not in Tie-sEH Tr mice, GO6976 (1 lM) and PD58059 (1 lM) significantly enhanced pinacidil-induced relaxation; HET0016 (10 lM) had no effect in either of the phenotypes of mice (Fig. 7a, b) . We found no significant effect of PD58059, HET0016, and GO6976 on the PE-induced contractions (data not shown). Together, these data suggest that sEH over-expression modulated vascular tone by inhibiting K ATP channel-dependent vascular relaxation in MAs.
Discussion
This study found that sEH modulated AR and K ATP channel-dependent vascular responses in MAs. Specifically, in MAs from Tie2-sEH Tr mice (a) NECA-induced vascular relaxation was reduced; (b) CCPA-induced vascular contraction was enhanced; (c) CYP4A, ERK1/2, and PKCa were involved in higher CCPA contraction; (d) elevated expression of A 1 AR, CYP4A, and reduced p-ERK1/2 was present; and (e) in WT mice but not in TiesEH Tr mice, GO6976 (1 lM) and PD58059 (1 lM) significantly enhanced pinacidil-induced relaxation; HET0016 (10 lM) had no effect in either of the phenotypes of mice. Therefore, pinacidil-induced enhanced relaxation depends on the inhibition of PKCa and ERK1/2 activities in WT MAs but not in Tie2-sEH Tr mice.
Various studies revealed that a decrease in A 1 AR levels closely followed a decrease in sEH expression, and vice versa in sEH -/-and A 2A AR -/-mouse aortas [19, 21] . Additionally, sEH inhibition reduced A 1 AR-dependent aortic contractions in A 2A AR -/-mice [21] . These findings strongly suggested a potential role for sEH in regulating A 1 AR-dependent vascular function. Studies showed vascular effects due to the absence or inhibition of sEH, but how sEH over-expression affects AR-dependent vascular function is unclear. Since, over-expression of sEH is expected to reduce the EETs levels, and the reduction of EETs levels are believed to be responsible for enhanced vascular contraction against A 1 AR agonist. Also, sEH polymorphism in human population has been shown to affect arachidonic acid metabolism which is associated with cardiovascular diseases [3] . On the other hand, xhydroxylases (CYP4A11, CYP4F2) metabolize arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE) which has vasoconstriction effects. Genetic polymorphisms that cause either lower or higher activity of these enzymes (CYP4A family) are generally associated with higher risk of hypertension or hypotension [3] . Therefore, more research is needed to confirm this association and to better understand the pathophysiologic mechanisms using mouse model of vascular endothelial over-expression of sEH (Tie2-sEH Tr).
Therefore, we sought to investigate the alterations in AR-dependent vascular responses due to endothelial sEH over-expression by performing various functional and expression studies in isolated MAs obtained from Tie2-sEH Tr mice. Notably, in MAs, A 1 AR mediated contraction, while A 2B AR regulated relaxation to AR stimulation [26, 30] . We confirmed higher expression of sEH in Tie2-sEH Tr mice (Fig. 1a) . Endothelial-specific over-expression sEH was reported in blood vessels of brain in Tie2-sEH Tr mice [17] . Our data further revealed enhanced contraction to PE & KCl (Fig. 1) in Tie2-sEH Tr mice. There is an increased trend of t-ERK expression (Fig. 5c ) in Tie2-sEH Tr mice may have possible link, such as in other studies, phosphorylation activates ERK1/2, which subsequently inhibits myosin light chain phosphatase, contributing to calcium sensitization and enhanced contraction [32, 33] . Thus, endothelial over-expression of sEH in MAs demonstrated enhanced vascular contractile responses to PE in Tie2-sEH Tr compared to WT mice.
We further investigated the modulation of AR-dependent vascular responses in Tie2-sEH Tr mice. As suggested by previous studies [19, 21] concerning the interaction between A 1 AR and sEH in mouse aorta, our data indicated the reduced NECA-induced vascular dilation (Fig. 2) and enhanced vascular contractions to CCPA (Fig. 3a) in MAs from Tie2-sEH Tr mice, revealing the involvement of enhanced A 1 AR-dependent vascular contraction in MAs of sEH over-expressed mice. Previous work in MAs suggested that activation of A 1 AR could inhibit A 2B AR-dependent vascular relaxation. A 1 AR-dependent contraction involved CYP4A and ERK1/2 [26] . We also found that CYP4A, PKCa, and ERK1/2 were involved in A 1 AR-dependent contractile responses in mouse aorta [20, 24, 25] . The present study found that higher contractile responses to an A 1 AR-agonist (CCPA) involved CYP4A, ERK1/2, and PKCa (Fig. 3b) . In support of our functional data (Figs. 2,  3) , we found higher expression of A 1 AR (Fig. 4a) and CYP4A (Fig. 4b) in MAs from Tie2-sEH Tr mice. Studies in coronary artery smooth muscle showed that activation of A 1 AR was linked to activation of phospholipase C, PKC-a, and increased p-ERK1/2 signaling [22] . Notably, ERK1/2 is activated through tyrosine phosphorylation [34] . Contrary, in the present study, we found low basal p-ERK/t-ERK ratio (Fig. 5b ) in Tie2-sEH Tr compared to WT mice with increased trend of total ERK1/2 in Tie2-sEH Tr compared to WT mice (Fig. 5c ). Low ratio of basal p-ERK/ t-ERK could be possibly complimentary in maintaining basal vascular tone in Tie2-sEH Tr compared to WT mice. While in response to stimulus such as CCPA, could be potentiating the contractile responses. In addition, no increase in the level of PKCa (Fig. 5e ) was observed. Though, it was reported that PKC phosphorylated ERK1/2 in PBDu-treated cerebral artery smooth muscle cells [35] . Overall, our data revealed that over-expression of sEH enhanced A 1 AR-dependent contraction. Also, our data showed higher expression of A 1 AR, CYP4A, and reduced p-ERK/T-ERK ratio. K ATP channels are major regulators of vascular function [27] . We previously reported that K ATP channels were involved in A 2A AR-stimulated mouse aortic relaxation [29] . Also, in mouse MAs, K ATP channels played a role in A 2B AR-dependent vascular relaxation such that inhibition of K ATP channel produced contraction of MAs in response to NECA, through activation of A 1 AR [26] . Thus, K ATP channels are important signaling components that mediate AR-dependent vascular relaxation. Considering the previous findings that sEH modulated AR expression and function [19, 21] and our current findings, we speculated that sEH may inhibit K ATP channel-dependent relaxation, which may further promote AR-dependent contractile responses. As expected, our data revealed that K ATP channel-induced vascular relaxation was reduced in Tie2-sEH Tr mice MAs (Fig. 6) . Furthermore, our data in WT mice revealed that K ATP channel-dependent dilation was enhanced by pharmacological inhibition of ERK1/2 and PKCa (Fig. 7a) . This suggested that ERK1/2 and PKCa play roles in the regulation of K ATP channels. In accordance with our findings, studies in pial arteries of piglets showed that hypoxic/ischemic injury activated ERK1/2, which in turn inhibited K ATP channel-dependent vasodilation [36] . To the contrary, studies in sarcolemmal K ATP channel-transfected human embryonic kidney 293 cells and ventricular cardiomyocytes isolated from rabbit showed that nitric oxide donors activated ERK1/2, which facilitated K ATP channel opening, thereby ensuring protection against ischemic or hypoxic injury [37] . These findings and our results indicate that ERK1/2 may function differentially, depending on the tissue and species involved.
Our finding of PKCa's involvement in K ATP channel regulation (Fig. 7a) was supported by the fact that PKC phosphorylates K ATP channels, inhibiting their activation [28] . In addition, studies in rat MAs revealed that K ATP channels were blocked by increased intracellular calcium but were unaffected by PKC inhibition, which contributed to UTP-induced contraction [38] . This study used PKC inhibitory peptides, while our study used the pharmacological inhibitor GO6976. In a study by Panhwar et al., no reduction in ET-1-induced contraction of MAs was observed [38] , whereas PKC was involved in ET-1-induced contraction in porcine coronary artery smooth muscle cells [39] . This suggests that species variation in PKC action could not be ruled out. Our data further revealed no involvement of CYP4A in basal K ATP channel function (Fig. 7a) . Overall, our data suggested the involvement of PKCa and ERK1/2, but not CYP4A, in the regulation of basal K ATP channel function in WT MAs. We further investigated the mechanisms of K ATP channel-dependent relaxation of MAs in Tie2-sEH Tr mice. Our data revealed that K ATP channel-dependent MAs relaxation is independent of p-ERK1/2, PKCa, and CYP4A in MAs from Tie2-sEH Tr mice (Fig. 7b) . The absence of any effects of pharmacological inhibition of PKCa and ERK1/2 in Tie2-sEH Tr MAs may possibly be due to higher levels of ERK1/2. Nevertheless, our data showed that sEH over- 
Conclusions
Our data showed that higher endothelial expression of sEH positively regulated vascular contractions in MAs. We found CCPA enhanced A 1 AR-dependent and CYP4A, PKCa, and ERK1/2-mediated contraction in MAs. Furthermore, our data showed that sEH over-expression negatively regulated K ATP channel function. Enhanced A 1 ARdependent contraction and reduced K ATP channel-dependent relaxation together potentiate overall contraction in sEH over-expressing mice MAs (Fig. 8) . Similarly, in endothelial sEH over-expressing mice, the vasodilation was impaired in the mouse cerebral artery [17] . It was previously shown that genetic deletion and inhibition of sEH was protective in myocardial ischemia-reperfusion injury in vivo [13] . Moreover, sEH inhibition decreased renal injury in hypertensive obese rats by improving vascular function [14] . sEH inhibition decreased blood pressure in angiotensin II-induced hypertension mice [15] . Therefore, sEH is an important target, and elucidating its mechanisms is imperative in cardiovascular pathophysiology. In this context, our study becomes immensely significant by suggesting mechanisms through which sEH regulates vascular tone. 
